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Transcription factor-based somatic cell 
reprogramming
In 2006, Takahashi and Yamanaka [1] demonstrated that 
differentiated cells can be converted into induced pluri­
potent stem cells (iPSCs) by the expression of four trans­
cription  factors  ­  Oct4,  Sox2,  Klf4  and  c­Myc  ­  which 
have been termed Yamanaka factors. From the per  spec­
tive of basic cell biology, somatic cell repro  gram  ming has 
radically  altered  our  thinking  on  the  plasticity  of  cell 
states. In addition, the derivation of iPSCs from numer­
ous  normal  and  diseased  cell  sources  has  enabled  the 
generation of patient­specific stem cells for eventual use 
in cell therapy and regenerative medicine. A number of 
alternatives and refinements to the original four­factor 
reprogramming  method  have  been  devised  over  the 
years. These have included ectopic expression of alter  na­
tive reprogramming factors, such as Nanog and Lin28, 
manipulation  of  pathways  that  act  as  barriers  to 
reprogramming, such as p53 and p21, transient expres­
sion of reprogramming proteins to avoid stable genetic 
modification,  and  inclusion  of  chemical  inhibitors  that 
increase the efficiency of the reprogramming process [2]. 
However, reprogramming largely remains dependent on 
the delivery and exogenous expression of one or more of 
the original Yamanaka factors.
The newly emerging role of miRNAs in 
reprogramming
In  a  recent  issue  of  Cell  Stem  Cell,  Morrisey  and 
colleagues [3] report that iPSCs can be generated solely 
through  the  expression  of  a  set  of  miRNAs,  thereby 
avoiding all original Yamanaka factors for the first time. 
This  breakthrough  is  destined  to  expand  our  under­
standing  of  the  pathways  that  drive  reprogramming. 
Using  lentivirus­based  expression  of  the  miR­302/367 
cluster  to  reprogram  both  mouse  and  human  cells, 
Morrisey  and  colleagues  [3]  show  that  miRNA­based 
reprogramming proceeds faster than with standard four­
factor  reprogramming.  Consistent  with  this  finding, 
pluri  potency  genes  such  as  Sox2,  Nanog  and  Rex1  are 
upregulated  earlier  in  fibroblasts  expressing  the 
miR­302/367 cluster than in fibroblasts transduced with 
the  four  transcription  factors.  Using  a  mouse  line 
expressing  a  reporter  gene  with  the  Oct4  promoter 
driving  green  fluorescent  protein,  the  authors  [3]  also 
show that the endogenous Oct4 locus is reactivated to a 
greater extent following miRNA expression than without 
miRNA expression. This rapid induction of endogenous 
pluripotency genes in the majority of target cells results 
in a significantly more efficient reprogramming process, 
up to two orders of magnitude higher than standard four­
factor  reprogramming.  The  authors  [3]  report  that  the 
miRNA­based approach can reprogram up to 10% of the 
input cells, although this could be an overestimation as 
only morphological criteria, and not pluripotency marker 
expression,  were  used  to  quantify  the  efficiency  of 
reprogramming of human fibroblasts.
Several miRNA families are expressed exclusively and 
at high levels in embryonic stem cells (ESCs) [4]. ESC­
specific  miRNAs,  such  as  the  miR­290  and  miR­302 
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© 2011 BioMed Central Ltdfamilies,  are  directly  regulated  by  the  pluripotency 
factors Oct4, Sox2 and Nanog and are thus integrated 
into  the  core  pluripotency  network  [5].  These  miRNA 
families  have  important  roles  in  ESC  self­renewal  and 
pluripotency,  as  knocking  out  either  of  the  two  key 
enzymes in miRNA biogenesis (Dicer and DGCR8) leads 
to  defects  in  ESC  proliferation  and  differentiation  [6]. 
Inhibition  of  Dicer  and  DGCR8  also  decreases  repro­
gramming efficiency, indicating that miRNA biogenesis is 
essential to robust reprogramming [7].
The  miR­302/367  cluster  used  by  Morrisey  and 
colleagues [3] is composed of five miRNAs, four of which 
(miR­302a­d) have the same seed sequence ­ a seven base 
pair  stretch  of  nucleotides  that  determines  target 
specificity.  The  miR­302  family  belongs  to  a  subset  of 
miRNAs referred to as ESC­specific cell­cycle­regulating 
(ESCC)  miRNAs  that  regulate  the  G1­S  transition  and 
can rescue the cell cycle defect of DGCR8­null ESCs [8]. 
Another set of ESC­specific miRNAs, the miR­290 family, 
has  been  shown  to  substitute  for  c­Myc  expression 
during reprogramming [9]. Recent work has revealed that 
the miR­302 and miR­290 family members both target 
many  genes  in  several  pathways,  such  as  cell  cycle 
regulation  (Cdk1na,  Rbl2)  and  epithelial­mesenchymal 
transitions (RhoC and Tgfbr2) [9]. Many of these target 
genes  are  functionally  important,  as  inhibiting  them 
individually using siRNAs or chemical inhibitors can also 
enhance four­factor reprogramming [9]. The seed sequence 
of the other miRNAs used in the new report [3], miR­367, 
is different from that of the miR­302 family. Importantly, 
exclusion of miR­367 from the miRNA cocktail abrogated 
reprogramming.  In  fact,  without  miR­367,  endogenous 
Oct4  is  never  activated,  suggesting  that  this  miRNA 
either  directly  or  indirectly  regulates  Oct4  expression. 
Given the wide variety of cellular processes targeted by 
these miRNAs, it is likely that simultaneous suppression 
of multiple targets is key to their reprogramming ability 
(Figure 1).
Potential mechanisms of miRNA-based 
reprogramming
Although miRNA­based reprogramming did not require 
expression of any Yamanaka factors, reprogramming of 
mouse  cells  with  the  miRNAs  did  require  the  use  of 
valproic  acid  (VPA),  a  histone  deacetylase  (HDAC) 
inhibitor. Interestingly, VPA and other HDAC inhibitors 
have  previously  been  shown  to  enhance  four­factor 
reprogramming  [10].  Using  fibroblasts  derived  from 
HDAC2 null mice, the authors [3] demonstrate that the 
effects of VPA are entirely dependent on the presence of 
this protein. Moreover, human fibroblasts express lower 
levels  of  HDAC2  than  mouse  fibroblasts,  which  may 
explain  why  miRNA­based  reprogramming  of  human 
cells does not require VPA.
As  in  all  standard  retro­  and  lentiviral­based  repro­
gram  ming methods, exogenous lentiviral miRNA expres­
sion is eventually silenced in the resulting iPSCs, when 
the endogenous pluripotency genes become reactivated. 
Because  miRNAs  primarily  act  as  repressors  of  gene 
expression through mRNA degradation or inhibition of 
translation,  it  will  be  interesting  to  know  how  the 
endogenous  pluripotency  factors  become  activated 
during this process. In differentiated somatic cells these 
factors  are  kept  silent  by  a  combination  of  DNA  and 
histone methylations; therefore, the miRNAs must some­
how prompt the removal of these repressive chromatin 
marks [2]. A plausible scenario might be one in which the 
miRNAs  target  the  enzymes  that  maintain  these 
epigenetic marks. Inhibition of HDACs, which seem to 
be essential for miRNA­based reprogramming, at least in 
mice,  may  then  shift  the  balance  towards  histone 
acetylation and transcriptional activation. Even then, how 
reprogramming is initiated in the absence of any strong 
transcriptional activator remains unresolved.
The future of miRNA-based reprogramming
Apart from the fascinating biological questions raised by 
this report [3], miRNA­based reprogramming has impor­
tant  practical  implications.  Alternative  methods  of 
miRNA delivery, such as transfections of miRNA mimics, 
are worth pursuing as a way to generate iPSCs with no 
genomic integrations. Although there are non­integrating 
methods  of  delivering  the  Yamanaka  factors,  the  low 
Figure 1. miRNA-mediated reprogramming. miRNAs achieve 
reprogramming potentially by repressing the repressors of 
pluripotency genes. Genes involved in cell cycle progression, 
epithelial-mesenchymal transition (EMT) and epigenetic regulation 
are among genes that are targeted by the miR-302/367 cluster, but 
there are probably multiple important targets yet to be determined. 
Inhibition of HDAC2 by VPA, in conjunction with the miRNAs, is 
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adoption. As miRNA­based reprogramming seems robustly 
efficient, even non­integrating methods such as miRNA 
transfection may generate appreciable numbers of iPSC 
clones. If rapid and efficient reprogramming by transient 
miRNA delivery becomes a reality, routine iPS derivation 
for future clinical applications may rely entirely on this 
method.
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